Emergent Biosolutions (GB:0IGA)
LSE:0IGA
Holding GB:0IGA?
Track your performance easily

Emergent Biosolutions (0IGA) Financial Statements

1 Followers

Emergent Biosolutions Financial Overview

Emergent Biosolutions's market cap is currently ―. The company's EPS TTM is $-11.248; its P/E ratio is -0.54; Emergent Biosolutions is scheduled to report earnings on November 6, 2024, and the estimated EPS forecast is $-0.09. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 254.70M$ 300.40M$ 269.90M$ 270.50M$ 335.20M
Gross Profit$ -41.40M$ 155.80M$ 84.80M$ 93.70M$ 144.60M
EBIT$ -269.80M$ 36.40M$ -32.80M$ -246.20M$ -221.60M
EBITDA$ -236.30M$ 71.20M$ -3.20M$ -212.50M$ -179.80M
Net Income Common Stockholders$ -283.10M$ 282.90M$ -49.50M$ -263.40M$ -261.30M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 69.70M$ 78.50M$ 111.70M$ 87.80M$ 88.60M
Total Assets$ 1.51B$ 1.80B$ 1.82B$ 1.89B$ 2.18B
Total Debt$ 862.20M$ 905.90M$ 860.20M$ 861.80M$ 903.20M
Net Debt$ 792.50M$ 827.40M$ 748.50M$ 774.00M$ 814.60M
Total Liabilities$ 1.13B$ 1.14B$ 1.17B$ 1.20B$ 1.22B
Stockholders Equity$ 386.30M$ 663.90M$ 649.30M$ 697.20M$ 956.30M
Cash Flow-
Free Cash Flow$ 42.90M$ -73.40M$ 20.70M$ 47.40M$ -127.30M
Operating Cash Flow$ 47.50M$ -62.60M$ 32.10M$ 60.00M$ -114.80M
Investing Cash Flow$ -4.60M$ -10.80M$ -11.40M$ -18.90M$ 258.10M
Financing Cash Flow$ -50.90M$ 40.70M$ 4.70M$ -43.00M$ -486.90M
Currency in USD

Emergent Biosolutions Earnings and Revenue History

Emergent Biosolutions Debt to Assets

Emergent Biosolutions Cash Flow

Emergent Biosolutions Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis